|
|
 |
Neil Adams, ISMPP CMPP™ Neil has worked in medical publishing for the past 20 years at companies such as John Wiley & Sons, Springer Science & Business Media and Informa Healthcare. He is currently publishing manager for the Pharma Solutions division at Nature Publishing Group (NPG), where he works with pharmaceutical and medical communications companies, journal editors and researchers to publish clinical studies in NPG journals. An active member of ISMPP, he currently serves on its ISMPP U committee, and has also been a workshop faculty member at the European and Annual meetings. Neil received his B.A. from Bates College and is an ISMPP Certified Medical Publication Professional. |
 |
Gregory Bezkorovainy, MA, ISMPP CMPP™ Gregory Bezkorovainy is Vice President of Scientific Services at Adelphi Communications in New York. He entered the healthcare communications field in 1988, just as strategic publications planning was taking root in the pharmaceutical industry. Over the years he has worn almost every publications planning hat imaginable, including medical reporter, editor, writer, designer, tactical planner, and strategic planner. Gregory joined Adelphi, Inc in 2002 and has been in his current position since 2006. This is Gregory's sixth consecutive year as faculty for Introduction to Publications Planning. |
 |
Barbara E. Bierer, MD Barbara E. Bierer, M.D., a hematologist-oncologist, is Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital. Dr. Bierer co-founded and now leads, as faculty co-director, the Multi-Regional Clinical Trials (MRCT) Center at Harvard, a University-wide and collaborative effort to improve standards for the planning and conduct of clinical trials in the developing world. In addition, she is the Program Director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award. From 2003-2014, she served as Senior Vice President, Research, at the BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. In addition, she was the Co-Chair of the Partners HealthCare Committee on Conflict of Interest. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award in 2008. In addition to her academic responsibilities, Dr. Bierer served on the Board of Directors of both the Association for Accreditation of Human Research Protection Programs (AAHRPP) and the Federation of American Societies for Experimental Biology (FASEB). She served as the Chair of the Secretary’s Advisory Committee for Human Research Protections, Department of Health and Human Services from 2008-2012. She is currently a member of the National Academies of Sciences Committee on Science, Technology and the Law. She also serves on the Board of Directors of Public Responsibility in Medicine and Research (PRIM&R), dedicated to promoting the ethical conduct of biomedical and behavioral research; Management Sciences for Health (MSH), an international organization working in partnership globally to strengthen health care, local capability, and access; and the Edward P Evans Foundation, a foundation supporting biomedical research for which she serves as Chair. She has authored or co-authored over 180 publications and is on the editorial boards of a number of journals including Current Protocols of Immunology. Dr. Bierer received a B.S. from Yale University and an M.D. from Harvard Medical School. |
|
LeeMing Boo Bio coming soon |
|
 |
Dan Bridges, PhD, ISMPP CMPP™ Dan is currently the Regional Director for Europe and China at Nucleus Global, where he is responsible for the 7 medical communication agencies (Articulate Science, Cognito Medical, Health Interactions, Medical Expressions, Meditech Media, Meditech Media China & Scimentum) that support clients across these regions and globally. In his 13 years in medical communications, Dan has specialised in building integrated publication planning offerings in both the clinical and HEOR fields and has led global and affiliate publication plans across multiple therapeutic areas and all stages of the product lifecycle. He has also provided extensive consultancy support to clients in the development of publication SOPs and integration of best practice guidelines. He currently serves on the ISMPP Board of Trustees and was an author on both GPP2 and GPP3. Prior to his medical communications career, Dan gained an MSC in Biochemistry from the University of Bath, UK and a PhD on the clinical use of cannabinoids for neuropathic pain from Imperial College London, UK (in collaboration with Novartis). Back to top |
 |
Gary Burd, PhD, ISMPP CMPP™ Gary has 13 years of medical communications and scientific publishing experience. He joined McCann Complete Medical in 2006, and is now SVP, Global Medical Director for Caudex, based in their New York office. Gary has led communication planning and publication planning activities in several therapy areas and has collaborated with teams in many European and US pharmaceutical companies, including Bayer Schering, Roche, Lundbeck, Novartis, Novo Nordisk, Boehringer Ingelheim, GSK, AstraZeneca, BMS, Merck Serono, EMD Serono, Pfizer, and, more recently, Japanese pharmaceutical companies Chugai and Mitsubishi Tanabe. Prior to his medical communications career he gained valuable editorial experience in journal publishing with Portland Press. Gary obtained his PhD from the Kennedy Institute of Rheumatology, London working on a monoclonal antibody therapy for systemic lupus erythematosus. |
 |
Todd Carpenter Todd Carpenter is Executive Director of the National Information Standards Organization (NISO), a US-based non-profit industry trade association that fosters the development and maintenance of standards that facilitate the creation, persistent management, discovery, and effective interchange of information in publishing and media. Throughout his career, Todd has served in a variety of roles with organizations that connected the publisher, library and software communities. Prior to joining NISO, Todd had been Director of Business Development with BioOne. He has held management positions at The Johns Hopkins University Press, the Energy Intelligence Group, and the Haworth Press. He is a graduate of Syracuse University and holds a masters in business from the Johns Hopkins Univeristy. Todd is also editor of The Critical Component: Standards in Information Distribution published by the American Library Association. |
 |
Dheepa Chari, MS Dheepa Chari has 15 years of experience in the pharmaceutical/biotech industry in various roles creating and executing strategic data communication plans, medical expert engagement plans, and clinical research activities. She currently works at Novartis Pharmaceuticals as Director of US Oncology Scientific Communications, focusing on medical strategy development, publication planning, and scientific resource development for the rare disease and renal cell carcinoma franchises. Previously, she worked on Amgen’s Medical Communications team for over 4 years, where she led publication planning activities on the rheumatology and dermatology programs and pipeline products. In addition to her publications experience, she worked in study management and data management roles for several years at both Amgen and Pfizer across various therapeutic areas, including supportive care oncology, CV/metabolic, and neuroscience. Dheepa holds a Master of Science degree in Biostatistics from Columbia University and a Bachelor of Science degree in Biochemistry from Southern Methodist University. She is currently a member of ISMPP and TIPPA. |
|
Hilary Carson, MBS Bio coming soon |
|
 |
Christopher Carswell, MSc Chris Carswell has been the Editor in Chief of PharmacoEconomics for over ten years, is the co-editor of The Patient: Patient-Centered Outcomes Research and the consulting editor of Applied Health Economics and Health Policy. He also leads a team of six other professional journal editors in the fields of pharmacoeconomics, pharmacovigilance and pharmacokinetics.. He practised as a pharmacist for over 10 years before becoming a medical writer and then a full-time professional journal editor with Adis publications in 2001. Chris was a lead author on the CHEERs reporting guidelines for economic evaluations and is also an author on GPP-3 taking the lead on the guidelines for authorship and author payment sections. |
 |
Alice Choi, PhD, ISMPP CMPP™ Alice Choi is currently the Global Head of Complete Medical Communications (CMC), a division of McCann Complete Medical. Alice has an honours degree in Pharmacology, a Masters Degree in Clinical Pharmacology, a Masters in Public Health and a doctorate in cancer epidemiology. Pre CMC, Alice began her career in academia as a researcher before moving on to a number of healthcare agencies, working in medical communications, market research and health outcomes. |
 |
Juli Clark, PharmD Juli has directed the Global Medical Writing department at Amgen for 9 years, and has 19 years of experience in the biotech industry, having managed staff and services in Medical Writing, Medical Information and Medical Communication roles. Prior to working in industry, she worked for two smaller companies (Pathogenesis, and Otsuka). Juli earned her B.S. Pharmacy and Doctor of Pharmacy degrees at University of Iowa, and completed a General Hospital Pharmacy Residency program and Fellowship in Ambulatory Care Clinical Pharmacy. Prior to entering the biotech/pharma industry, Juli practiced as a clinical pharmacy specialist in a variety of settings including managed care, Indian Health Service, private and large University Hospitals. Juli is currently serving Vice Chair of the 12th Annual Meeting of ISMPP and has been an active participant/presenter in the Medical Publishing Insights and Practices Initiative (MPIP) as well as with ISMPP, AMWA and DIA. |
 |
Jocalyn Clark, PhD Dr. Jocalyn Clark is a professional journal editor based in London UK. She was appointed Executive Editor at The Lancet in March 2016. From 2013-16 she served as Executive Editor at icddr,b, a large public health research organisation in Dhaka, Bangladesh and the Journal of Health, Population, and Nutrition (JHPN) until it was acquired by BioMed Central in June 2015. Previously Jocalyn was Senior Editor at PLOS Medicine (2008-13) and an Assistant Editor at The BMJ (2002-07). She is also an adjunct Assistant Professor of Medicine at the University of Toronto. In 2013, Jocalyn was a fellow of the Rockefeller Foundation’s Bellagio Center for her writing project on “the medicalization of global health.”
|
 |
Tim Collinson, BSc, ISMPP CMPP™ Tim has worked in global medical communications for 20 years, in roles in the UK, USA and Canada. His background includes medical editing and writing positions, in-house (global brand team) support for a leading pharma company, and Editorial Director and Operations Director roles within the Fishawack Group. In 2014, Tim established the Fishawack Group’s US West Coast operation in San Francisco. Tim is a Certified Medical Publication Professional, a member of the ISMPP Certification Board (Voting Director, 2015-2017), and Co-Chair of the ISMPP Asia Pacific Education Taskforce. He has led workshops at ISMPP annual meetings, and has been a presenter at the past two International Publication Planning Association (TIPPA) annual meetings. Tim has many years of experience in publication planning, journal and congress publications, advisory boards, symposia and educational material. He currently provides client service, editorial direction and technical leadership for a range of products and services in variety of therapeutic areas. He has an honors degree in Physiology/Pharmacology with Health Studies, and research experience at the Justus Liebig University Hospital, Giessen, Germany. |
 |
Nicholas Combates, PhD, ISMPP CMPP™ Nick is an Associate Director in Global Scientific Communications at Celgene supporting Multiple Myeloma. He earned his PhD in Cell and Developmental Biology from Rutgers University. While a post-doctoral scientist at Novartis and J&J he conducted preclinical research in oncology and dermatology. He is an author on over a dozen peer-reviewed publications. Nick has over 15 years experience in strategic publication planning and development. He started as a medical writer and then became a medical director at a Medical Communications Agency working with several major pharmaceutical companies. Nick then joined Aventis (later Sanofi) and led publications development in respiratory and oncology. Nick is a Certified Medical Publication Professional and has been an ISMPP member since its inception. |
 |
Grahame Conibear, BSc |
 |
Morgan deBlecourt Morgan deBlecourt is an editor and publications manager at the Duke Clinical Research Institute, the largest academic research organization in the world, which is located in Durham, North Carolina. Morgan came to the DCRI, part of the Duke University School of Medicine, in 2010. Morgan received her undergraduate degree in journalism at Marshall University in her home state of West Virginia. In addition to volunteering at their church, Morgan and her husband David spend most of their spare time with their son, Elliot. |
 |
Jonathan Druhan, PhD Jon Druhan is Director of US Publications at AstraZeneca Pharmaceuticals LP. His background includes a BSc from McGill University, MA and PhD degrees in Biopsychology from the University of British Columbia in Vancouver, Canada, and more than 35 years of scientific communications work in both academic and industry settings. Earlier in his career, Jon held successive tenure-track faculty positions in Psychiatry Departments at MCP-Hahnemann University and the University of Pennsylvania. Jon subsequently went on to pursue opportunities in the Medical Communications field, initially working as a medical writer at Trinity Communications and Scientific Connexions, and then working as Assistant/Associate Director of Publications at Johnson & Johnson. He joined AstraZeneca in 2006, and managed their US-based publications professionals for over 5 years. During this time, Jon served as Chair of the Ethics Committee for the International Society for Medical Publications Professionals (ISMPP) and he frequently presented on issues related to publications ethics and best practices at ISMPP meetings and Center for Business Intelligence forums on Publication Planning. In 2011, he took on the role of Medical Scientific Compliance Director, providing policy and compliance support to AstraZeneca’s US Medical Affairs department. During his three years as Compliance Director, Jon developed broad expertise in policy and regulatory issues related to scientific exchange and medical communications. He recently returned to the field of Medical Publications in October 2014 and has since been serving as Publications Director for the Publications Group within US Medical Affairs at AstraZeneca. |
 |
Marion Enie, ISMPP CMPP™ Marion has been with Envision since 2006 assuming increasing responsibilities and leading teams across multiple accounts and therapeutic areas. Marion co-leads Consulting Solutions where she leverages her broad expertise specializing in evidence-based strategic communication planning including therapeutic landscape, needs assessment and scientific platform development throughout all stages of the product lifecycle. Marion began her career with as clinical medical technologist with a specialty in hematology. She left the clinical world to take a position with Boehringer Mannheim Diagnostics (now Roche) in the development and marketing of medical devices. Through an interest in product development, Marion accepted an appointment at Indiana University as Manager of Technology Transfer where she collaborated between the University and industry to help commercialize the University’s intellectual property. Marion then returned to industry spending 7 years at Eli Lilly and Company, where she supported the launch of multiple products in diabetes and CNS. She was also part of a task force that initiated scientific data disclosure strategy in order to improve and standardize policies and processes to support the communication of scientific data. Marion is active in the International Society of Medical Publications Professionals (ISMPP) and has served on the Annual Meeting Workshop Committee from 2009-2011. She also holds the Certified Medical Publications Professionals (CMPP) certification. Marion received her BS degree in Biology from California State University, California, PA and a Certificate in Industrial Chemistry and Business Management from Chatham College, Pittsburgh, PA. |
 |
Keith Evans, PhD Keith Evans holds qualifications in Economics (BA Econ) and Health Economics (PhD) from Leicester University. He worked as a lecturer in economics at Leicester Polytechnic/De Montfort University for five years. Keith then worked as Health Economist and later Director of Health Services Research Unit (UCNW Bangor) and has also worked for Ayrshire & Arran Health Board (UK NHS) as health economist in the department of Public Health. Keith has worked in medical communications agencies for the past ten years specializing in health outcomes and evidence-based medicine projects. His current role is to provide specialist health outcomes input into InScience Communication medical communication services. |
|
Lorna Fay Bio coming soon |
|
 |
Sarah Feeny, BMedSc, ISMPP CMPP™ Sarah L Feeny is Global Head of Scientific Direction at Complete Medical Communications, head-quartered in the UK. Sarah studied medicine at the University of Nottingham Medical School in the UK, but deciding she would make a very poor healthcare professional, she changed track and became a biomedical writer/indexer in 1993. She moved to Complete Medical Communications in 1998 and has extensive experience in the field of ethical publication planning and delivery. She has also assisted in the development of industry publication planning SOPs and policy documents, as well as running industry training on good publication practice. Sarah is a charter member of ISMPP, past Chair of the European Committee of ISMPP (2008-2011) and held the European At-Large position on the ISMPP Board of Trustees (2011-2014). You can follow Sarah on twitter @iamsarahfeeny. |
 |
Janet Forrester Janet Forrester holds a PhD from McGill University in Epidemiology and Biostatistics. She currently holds a position as an Associate Professor in the Department of Public Health & Community Medicine at the Tufts University School of Medicine. She is the Associate Director of the Tufts University Doctorate in Public Health degree and Course Director for Epidemiology and Biostatistics (Health Communications 502). Over that past 20 years, she has conducted epidemiologic studies, including randomized trials, in the area of infectious diseases and nutrition. She is a consulting statistical editor for the journal Clinical Therapeutics. |
 |
Meg Franklin, PharmD, PhD Meg has over 10 years of experience in the health economics and outcomes research arena. She has consulted for pharmaceutical consulting companies, and spent several years in academia as an Associate Professor at the Presbyterian College School of Pharmacy in South Carolina. Over the last decade she has written numerous scientific publications, conducted retrospective database studies, developed economic models, drafted value messages, and provided strategic consulting to pharmaceutical companies. Her primary expertise is in research design and methodology, particularly retrospective analyses. She holds a PharmD and PhD from the University of South Carolina. Dr. Franklin has worked across a myriad of therapeutic areas. Recent areas of focus include the following: oncology (pancreatic, lung, and breast cancers, multiple myeloma, melanoma, and chemotherapy induced nausea and vomiting), hepatitis, diabetes, cardiovascular disorders, epilepsy, multiple sclerosis, hemophilia, and rheumatoid arthritis. She also has experience working with rare/orphan diseases. Prior to entering the HEOR arena, she completed an ASHP accredited pharmacy practice residency and worked as a clinical pharmacist. |
 |
Jeffrey Frimptor, MPH Jeff has worked in scientific publishing and communications for more than 15 years, including a focus in market access and evidence-based medicine since his time at Sanofi. Jeff specializes in the content and operational aspects of investigating, communicating and translating the value of health technology to its stakeholders. Jeff started his own consulting firm, Integrative Life Sciences, in 2015 to continue to work across healthcare stakeholders with special attention on these and related areas. |
 |
Christine Gatchalian, PhD Christine Gatchalian PhD, Director, leads the Oncology and Hematology/Oncology teams in Global Medical Writing. Christine has accumulated 21 years of experience in the biopharmaceutical industry, the last 8 of which have been in scientific publications. She joined Amgen Global Medical Writing in 2004, briefly supporting pipeline product teams in Oncology before assuming the role of Bone therapeutic area lead. In this capacity, Christine developed teams of medical writers supporting all indications for denosumab and a pipeline product. Prior to 2004, Christine led a team of medical writers and a graphics specialist at Kendle International, which provided dedicated publication support on Amgen products. Christine received her PhD in Neural Sciences from Washington University in St. Louis. |
 |
Kim Gertsen |
|
Namit Ghildyal, PhD Bio coming soon |
|
 |
Seth J. Goldenberg, PhD Seth J. Goldenberg is currently the Director of Product Development Strategy with NAMSA, previously the Director of Global Regulatory at NAMSA, and a former member of the U.S. FDA. He holds a Ph.D. in Pharmacology from the University of Washington and a M.S. from the School of Biomedical Engineering at Drexel University. At NAMSA Dr. Goldenberg works with over 750 NAMSA associates to develop global strategies for success taking into account regulatory, clinical, testing and business considerations around the world. He has supported companies in direct interactions with the US FDA, several notified bodies, CFDA, ANVISA, MFDS, and many others global regulatory bodies. Prior to joining NAMSA Dr. Goldenberg founded a consulting company based in Shanghai supporting medical device market entry. Dr. Goldenberg understands not only what it takes to carry out scientific study, but also the importance of communicating it with the global scientific community to foster partnerships and collaboration, demonstrated by his strong publication record in such journals as Cell, Science, and Nature Cell Biology that have been cited over 900 times. |
|
Keith Goldman, MA Bio coming soon |
|
 |
Lynn Gordon, MPH, ISMPP CMPP™ Lynne has a wealth of experience with over 20 years in the pharmaceutical industry working in both large pharma and start-up biotech companies. She was a field-based Medical Science Liaison (MSL) for 15 years in a number of therapeutic areas: Infectious diseases, gastroenterology, pulmonology, allergy, otolaryngology and oncology. For the past 5 years, Lynne has been in-house at Theravance Biopharma US, Inc. She was the third person in the Medical Affairs Department, which has grown to twenty, including the field based team. |
 |
Jim Gurr, PhD Jim Gurr, PhD, has over 15 years experince in publications in the pharmaceutical industry and is currently a Publications Lead, Oncology, in the Scientific Publications group at MedImmune. Prior to joining MedImmune, Jim held similar positions in the publications teams at Bristol-Myers Squibb, Pfizer and Wyeth. He has been a member of ISMPP since its inception and has served on the Annual Meeting Committee for the past 6 years.He is also an author on GPP2 and GPP3. |
 |
Zachary Hallinan Zachary Hallinan is the Director of Patient Communication and Engagement Programs at the non-profit Center for Information and Study on Clinical Research Participation (CISCRP). A graduate of the University of Pennsylvania, he oversees CISCRP's programs for better understanding and meeting the needs of clinical research volunteers globally, including programs to assist research sponsors in communicating clinical trial results to study volunteers in plain language. He has been recognized for his work and scholarship by the National Science Foundation, and was recognized by CenterWatch as one of twenty innovators changing the face of the clinical trials industry. |
 |
Mieko Hamana, ISMPP CMPP™ Mieko has extensive experience in the pharmaceutical industry. After studying business management in UK, where she obtained a post-graduate diploma from Westminster University, she started her career in the pharmaceutical industry. While at Pharmacia in Japan, she was engaged in various, but essential, aspects for pharmaceutical companies including: R&D resource planning, clinical development, portfolio management, HEOR, new product assessment and portfolio management, and product marketing. In 2003, she moved to Yamanouchi Pharmaceutical Company Ltd and worked in US for their Global function. In 2005, Yamanouchi became Astellas Pharma Inc. and further enhanced its globalization strategy. Mieko spent most of her career managing a global team to develop VESIcare which became a leading product worldwide to treat overactive bladder. She was responsible for establishing and implementing the global brand strategy while leading a cross-regional and cross-functional global team. Various studies were conducted according to the product life cycle; throughout this period, she engaged with authors and publication teams to help ensure manuscripts from these studies were submitted to peer-reviewed journals. In 2012, she moved to Medical Affairs function which was newly created at that time and fully dedicated for the company to be compliant with good publication practice. Mieko is a Certified Medical Publication Professional (ISMPP CMPP™). |
 |
Carolyn Hustad, PhD, ISMPP CMPP™ Carolyn has been with Merck since 2001, first as a medical writer, quickly progressing to become the group leader for the bone, respiratory, immunology and dermatology writing group. In 2010, she became the Director of the Publication Services group within the Global Scientific and Medical Publications Department, progressed to Executive Director in 2013, and assumed leadership of the department this year. She has a BS in Chemistry/Marine Science from the University of Miami and a PhD in Biochemistry and Molecular Biology from the University of Southern California. She completed her CMPP certification in 2014. |
 |
Brian Jenkins |
 |
Renu Juneja, PhD Renu Juneja is Head of the Medical Communications group at MedImmune (the worldwide biologics research and development arm of AstraZeneca). Her group has the responsibility for writing regulatory documents (clinical trial reports, summary documents, protocols, investigator brochures, briefing documents etc.) as well as publications (manuscripts, review articles .); for peer-reviewed journals and presentations (abstracts, posters, oral presentations etc) at the scientific meetings. Previously, she led the Strategic Scientific Communication (SSC) group at Novo Nordisk Inc. (NNI). She also had the opportunity to lead the Information & Education group at NNI and was responsible for the company’s library and for Independent Medical Education (IMEs) programs. Renu started her career in Novo Nordisk as a medical writer. After finishing her PhD in Reproductive Biology & Biochemistry from the Post Graduate Institute of Medical Education & Research (PGIMER) in India, Renu joined The Population Council in NY as a Postdoctoral fellow. Two years later, she received an independent research grant from the Lalor Foundation and joined the department of Molecular Biology at the Princeton University, She has over 20 publications in peer-reviewed journals and has presented at various national and international conferences. Renu has presented and conducted workshops at the annual meetings of various professional organizations e.g. ISMPP, TIPPA, CBI, and Q1 productions. |
 |
Christopher Kelly, MEd For the past 26 years, Chris has provided direct patient care, health education, professional training, and instructional design in a variety of health care and medical communications settings. Chris has also worked for 15 years as a senior health educator and trainer, leading instructional design, health literacy and content strategy for a pharma-based medical communications agency. During this time, Chris led the design and delivery of professional and patient education programs for pharma companies, health plans, advocacy organizations, home care and ambulatory care organizations. Chris has also presented and published on topics such as ADHD, Alzheimer’s disease, social listening, patient journey development and patient self-management. |
 |
Dustin Khiem, PhD Dustin Khiem has been involved in strategic scientific communications for over 7 years, and currently leads Medical Communications at Kite Pharma. Combining his PhD in immunology with his experience in management consulting, Dustin enjoys synthesizing complex concepts into digestible communication elements, particularly in the field of immuno-oncology. Before joining Kite, Dustin had successfully launched multiple oncology products while at Amgen, where he had either led or executed all aspects of medical affairs. Prior to Amgen, Dustin worked as a consultant with Campbell Alliance and was involved in developing strategic launch plans across commercial and medical affairs organizations. Dustin holds a PhD in Biomedical Sciences from University of California, San Francisco, and a Bachelor of Science degree in Molecular, Cellular, and Developmental Biology from Yale University. You may contact Dustin at [email protected]. |
 |
Tim Koder, PhD Tim is an Account Director at Oxford PharmaGenesis, supporting our pioneering clients on real world evidence communications. Right now, he leads a network within a top-10 global pharma company to develop and share best practice across local marketing companies and global experts. Gaining experience from Ogilvy Healthworld, Communigen, Caudex Medical and Informa Heathcare, Tim has worked in medical communications and publications for 12 years. With client service, writing and editorial backgrounds, Tim enjoys strategic planning and detailed delivery. Tim is still fascinated by neuroscience, especially in learning and memory, following postdoctoral research, PhD and MSc at the MRC Centre for Synaptic Plasticity at the University of Bristol and BSc Neuroscience from University College London. |
 |
Bhakti Kshatriya, PharmD Dr. Kshatriya has over 18 years’ experience in publication planning & execution, spanning from pre-launch preclinical stage to launch and through end of product lifecycle, including Rx-to-OTC switch. She has worked on a wide range of therapeutic areas, including hematology/oncology, respiratory, cardiovascular disease/anti-thrombosis, bone disease, anti-infectives, HIV, transplant medicine, dermatology and gastroenterology. Her experience includes working at major pharmaceutical companies as well as medical education companies, with her current posting within Global Scientific Communications at Novartis Oncology, where she is responsible for development/update of company policy & SOP related to publications, publication metrics and HCP payment/TOV transparency reporting. Prior to this, she has held positions with increasing responsibilities - leading Publication teams at ALTANA Pharma (now Nycomed), and Aventis Pharmaceuticals (now sanofi-aventis). |
 |
Christine Laine, MD, MPH, FACP Christine Laine, MD, MPH, is Editor-in-Chief of Annals of Internal Medicine and Senior Vice President of the American College of Physicians. She is board-certified in internal medicine and sees patients and is on the faculty at Jefferson Medical College in Philadelphia. Dr. Laine received her medical degree from SUNY Stony Brook, and completed residency at The New York Hospital (Cornell University) and fellowship in general internal medicine and clinical epidemiology at Beth Israel Hospital (Harvard University). Dr. Laine’s master of public health degree is from Harvard University. She holds leadership positions in the International Committee of Medical Journal Editors, the Council of Science Editors, and the World Association of Medical Editors. |
 |
Vincent Lima Vincent Lima, a senior assessment specialist at Professional Testing, Inc., has worked closely with the ISMPP Credentialing Board on the CMPP exam since 2010. At Professional Testing, he provides consulting, training, meeting facilitation, and analytical reporting to help credentialing agencies place new programs on a firm footing and continuously improve existing programs. Working previously at the Educational Testing Service, Mr. Lima wrote and reviewed questions for the Analytical sections of the Graduate Record Examination (GRE) and the Verbal sections of the Graduate Management Admission Test (GMAT). Later, at the American Institute of Certified Public Accountants, Mr. Lima was instrumental in developing the process for efficiently creating, reviewing, pretesting, and scoring realistic simulations of the work CPAs perform regularly. Mr. Lima is a member of the National Council on Measurement in Education and participates regularly in meetings of the Association of Test Publishers. Outside the testing industry, he has served as editor-in-chief of the weekly Armenian Reporter and as editor of a quarterly journal. He has taught at Tufts University and the University of Michigan, Ann Arbor. |
 |
Kristen Mack, ISMPP CMPP™ Kristen has worked in publications and communications for six years at Biogen and is currently an Associate Director leading publications in the Neurodegeneration Therapeutic Area. During her time in publications, Kristen has lead publication planning for multiple therapeutic areas and across the spectrum of life cycle products – marketed products, and pipeline compounds supporting launch readiness. She has not only lead the development of publication strategy and publications, but also has lead the development of global scientific platforms, lexicons, publication steering committees and spends time forming new publication teams for assets transitioning to clinical development. Kristen joined Biogen in 2007 as a medical science liaison supporting multiple sclerosis products. Prior to joining Biogen, Kristen worked for 7 years with Johnson and Johnson as a medical science liaison. Kristen is an ISMPP member and is a Certified Medical Publication Professional. |
|
Michael Mandola, PhD, ISMPP CMPP™ Bio coming soon |
|
 |
Jackie Marchington, PhD, ISMPP CMPP™ Jackie Marchington is Director of Global Operations and General Manager at Caudex, Oxford. Jackie joined Caudex in 1990 and has developed within the company in a range of mainly editorial roles, culminating in her current position. She develops and delivers both internal and external training on all aspects of medical publications, including publication ethics, compliance and copyright, and works with all Caudex offices to ensure understanding of and adherence to quality control protocols, as well as processes that contribute to the smooth and efficient development of projects. Jackie is a CMPP, co-chair of the ISMPP Advocacy and Outreach committee and a member of the Global Alliance of Publication Professionals (GAPP). |
|
Terry Materese Terry Materese is an Executive Publisher for Elsevier, with specialty lead responsibility for journal portfolios in clinical pharmacology, social and economic medicine, as well as management responsibility for journals in clinical neurology and anesthesiology. Terry has over 25 years of experience in leadership roles within national and international publishing organizations, growing, adapting and transforming media companies into strategic multi-media print, electronic and digital delivery providers. |
|
 |
Deborah Mayo, PharmD Debra holds a Bachelor of Science degree in Pharmacy from Temple University and a Master of Science degree, with a concentration in Health Care Administration and Health Care Education, from Saint Joseph's University in Philadelphia. She completed her Pharm D at the University of Florida. In her current role as Vice President of Global Scientific Communications at Teva Pharmaceuticals, Debra leads the medical communications and knowledge management groups. She has an additional breadth of knowledge and clinical skills from having practiced as a clinical pharmacist in a variety of healthcare settings. Additionally, she has held various industry positions within Medical Affairs. Debra has served as a pharmacy preceptor for over 20 years and as adjunct faculty for the University of the Sciences in Philadelphia |
 |
Rhiannon Meaden, PhD |
 |
Rina Mehta, MBA, PharmD Rina is currently a publication professional at Celgene Corporation, supporting the planning and development of HEOR/Market Access scientific communications. In the past, she has held positions in Medical Affairs strategic operations and planning and Market Access. Prior to joining the pharmaceutical industry, Rina was a practicing community pharmacist. Rina holds a MBA, in Pharmaceutical Management and Marketing, and PharmD from Rutgers University. |
 |
Ira Mills, PhD Ira Mills, PhD is a Senior Scientific Specialist at PAREXEL where he has worked for the past 3 years. Ira has broad experience in publications with 15 years at medical communication agencies and 20 years as a research scientist on the faculty at Brown and Yale University. Ira has published more than 40 peer-reviewed articles of original research and been an invited speaker at national and international congresses. Ira is an ISMPP member and has been an active presenter at recent ISMPP Annual Meeting poster sessions with 2 recent presentations focused on assessing social media in relation to publication activity and also presented on this topic at a recent ISMPP U focused on social media. Ira is currently serving on the ISMPP Annual Meeting Committee. |
 |
Karen Mittleman, PhD Karen has been with the Sanofi Group since 2003 and was previously Senior Director/Publications Compliance Officer in the Medical Expertise and Innovation Department of Global Medical Affairs. Her role as the Head of Publications within the CMO organization is to oversee development and review of scientific and medical publications across the GBUs and R&D as well as work closely with Data Sharing and Trial Transparency on clinical trial data dissemination. Karen has over 18 years of experience in clinical trial publication planning and development. She currently serves on the Standards Committee of the International Society of Medical Publication Professionals (ISMPP). Karen received a BSc from Penn State University, a Masters degree in Exercise Physiology from San Diego State University, and a PhD in Environmental Physiology from Simon Fraser University, British Columbia, Canada. She was a National Research Council Resident Research Associate with the Diving Medicine Department, Naval Medical Research Institute in Bethesda, Maryland, and was a postdoctoral fellow in renal physiology at Rutgers University. She was an assistant professor in Exercise Science at Rutgers before moving to medical communications. |
 |
Diane Moniz Reed, PharmD, ISMPP CMPP™ Diane Moniz Reed, PharmD, ISMPP CMPPTM is a strategic, solutions-oriented healthcare professional with more than twenty five years of experience enabling effective medical communications in both pharmaceutical industry and in the clinical setting. Passionate about change leadership, building new Organizational capabilities and developing high performing, customer-focused leaders, Diane currently serves as Group Director and Head of Oncology Medical Publications at Bristol-Myers Squibb. In this role she leads a team of publication professionals accountable for the development and execution of functionally and geographically integrated publication plans worldwide across the Immuno-Oncology and Hematology portfolios. Previously she held positions of increasing leadership in the Field Medical organization in multiple therapeutic areas. Prior to joining Bristol-Myers Squibb, Diane was a tenure-approved faculty member at Xavier University College of Pharmacy where she successfully established clinical pharmacy practices in critical care and emergency medicine at the Medical Center of Louisiana, New Orleans. She earned her Doctor of Pharmacy Degree from Howard University in Washington DC and completed residency training at Thomas Jefferson University Hospital in Philadelphia. A native of Rhode Island, Diane resides in New Jersey with her husband Gerry. Her personal goal is to “teach the world to fish”. |
 |
LaVerne A. Mooney, DrPH LaVerne obtained her BSc degree from Galway University, Ireland and was awarded her Masters and Doctor of Public Health from Columbia University School of Public Health, New York. For the last 9 years, LaVerne has been a Director and Team Leader of Publications in Pfizer Medical. LaVerne has represented Pfizer as a Steering Committee and Founding Member of the Medical Publication Insights and Practice (MPIP) collaboration. |
 |
Santosh Mysore, PhD Santosh Mysore has a PhD in Neuroscience from Medicine faculty of K.U.Leuven, Leuven, Belgium. After a brief post-doctoral stint at K.U.Leuven, Santosh joined as a consultant publications Manager at GSK, Wavre, Belgium. Santosh is currently working as ‘Lead Publications Manager, Pediatric Vaccines’ at GSK, Wavre, Belgium. |
|
Scott D. Newcomer, MS, ISMPP CMPP™ Scott Newcomer is the owner of Davenport Scientific Services, LLC. He has been working in the pharmaceutical industry since 1999 and specifically in scientific publications since 2002 at various companies, including Centocor/J&J, Cephalon/Teva, and ViroPharma/Shire. Scott has worked on products that treat patients with rare diseases for the last 5 years. Scott has an MS degree in Biology from the University of Houston and a BS degree from Juniata College. Scott is a Certified Medical Publication Professional and a member of ISMPP. |
|
 |
Mukund Nori, PhD, MBA, ISMPP CMPP™ |
 |
Paul O'Grady, PhD Paul O’Grady has worked in the medical communications sector for over 14 years, holding positions within both agencies and pharmaceutical companies. Paul received a doctoral degree in biochemistry from the University of Southampton, UK, and a bachelor's degree from King’s College, London. After obtaining his PhD, Paul relocated to the US, where he conducted post-doctoral research at the University of Rochester. He eventually moved to New Jersey, where he began working as a medical writer/director. Following work as a publication manager at Aventis/sanofi-aventis, he subsequently moved to Schering-Plough where he eventually assumed the role of Director of Global Publications in Global Medical Affairs. In this position, Paul was responsible for overseeing publications across the company, the product literature database, and production of US managed care dossiers. In 2009, he transitioned to the Global Scientific Communications group in Novartis Oncology, first as Director for New Products, subsequently becoming Senior Director overseeing a group which focused on the publications and medical education for everolimus (Afinitor), and across the company’s renal cell cancer and Breast Cancer portfolio. Recently, he has moved to overseeing digital solutions for GMA Oncology at the company working across all medical functions. He has been active in ISMPP for the last few years - co-running the Joy of Gap Analysis workshop of the ISMPP Annual Meeting for 4 years and serving on 2013, 2014 and 2015 Annual Meeting Program Committees. |
|
Antonia Panayi, PhD, ISMPP CMPP™ Bio coming soon |
|
 |
Todd Parker, PhD, ISMPP CMPP™ As VP of Scientific Services, Todd is responsible for implementation of the departmental vision; establishing and maintaining procedure, performance, and quality standards for staff; and overseeing department growth and staff development. Todd has over 12 years of medical communications agency experience overseeing publication planning and implementation and developing scientific and communication planning and training materials. Todd is also involved in identification and expansion of new service offerings (ie, development of innovative approaches to address client needs). His areas of expertise include biochemistry, drug development, immunology, infectious diseases, inflammation, and oncology. Before he joined MedThink SciCom, Todd worked at a medical communications company in the Midwest, where he provided scientific direction for multiple therapeutic areas in the oncology space, including immunotherapy, supportive care, and targeted agents. Todd earned his PhD in Biochemistry and Molecular Biology from Mississippi State University. He completed his postdoctoral research at Ohio University studying the mechanism of action of 2 biological response modifiers. Todd is also credentialed as a Certified Medical Publication Professional (CMPP) through the International Society for Medical Publication Professionals. |
 |
Ashwini Patil, MS Ashwini is a Principal Publication Writer in SIRO Clinpharm Pvt. Ltd. and has an overall 6.5 years of experience including international work experience in clinical research and healthcare domains at National Health Services, UK. She worked with a global pharma giant in clinical research and as a commissioning editor at Dove Medical Press, London. She is a Principal Publication Writer in SIRO’s scientific writing and communications group from past 4 years, and has handled numerous high-complexity and fast-track publications across therapeutic areas such as oncology, neurology, vaccines, psychiatry, pain, cardiovascular, immunology and infectious diseases for international journals and congresses. Currently, she mentors a team of 4 publication writers and is a peer-reviewer for the team. She is a trainer for new incumbents in the publication team and serves on the editorial panel for the company periodicals/newsletters. Prior to her scientific writing career, she gained MS in Drug Delivery from University College London School of Pharmacy and B. Pharmacy from University of Mumbai.
|
 |
Teresa L. Peña, PhD Terry Peña, PhD is a strategic, dynamic and results oriented leader with more than 15 years of experience in Medical Affairs and Diagnostics. She leads the Worldwide Medical Publications group at Bristol-Myers Squibb in the development of leading-edge publication governance, strategies, processes and plans. Prior to joining BMS, she led a team of scientists and publications professionals to deliver high-quality, scientifically rigorous, publication plans for the entire AstraZeneca portfolio of compounds/drugs. Before joining AstraZeneca, she held positions in publications at UCB and Abbott Labboratories where her responsibilities ranged from leading publication plans to process improvements and training, including development of corporate publication policy and streamlining publication practices. Terry started her career as a scientist in the Abbott Diagnostic Division and holds a PhD in Biology from Purdue University. Terry is an active member of ISMPP speaking at many of their events and holding a variety of key positions over the last several years. She will assume the role of outgoing Chair, ISMPP in April 2016. Terry is also as an active steering committee member of MPIP and GPP3 and a strong advocate of good medical publication practice and driving the communication of high quality science. |
 |
Kim Pepitone, BA, ISMPP CMPPTM |
 |
Heather Pierce, JD, MPH
Senior Director, Science Policy Regulatory Counsel, Scientific Affairs, Association of American Medical Colleges Heather Pierce is Senior Director for Science Policy and Regulatory Counsel at the Association of American Medical Colleges (AAMC). She serves as AAMC’s staff leader for scientific regulatory issues including clinical research, conflicts of interest, evidence-based regulation, and collaborations between industry, government, and academia in biomedical research. She is also the program leader for the AAMC’s Forum on Conflict of Interest in Academe and the co-director of Convey, the AAMC’s global financial interest disclosure system.
|
 |
Michael L. Platt, MS, ISMPP CMPP™ Chair, ISMPP Certifcation Board (2015-2016); President, MedVal and PharmaWrite Michael has over 20 years of industry experience and a broad knowledge of the pharmaceutical, biotechnological, and healthcare fields and includes pre-launch, launch, and post-launch activities, including publication planning and adult-based education. Michael has worked in continuing education for 10-plus years including credentials/certifications in physician and pharmacy education. Michael manages a team of professional writers, scientific managers, editors, meeting planners, and designers at MedVal and PharmaWrite who develop compliant medical and clinical communications, including publications. Michael is the Chair of the CMPP Board. He is also an active member of the ISMPP U Committee. As a past-Chair of ISMPP U, Michael assisted in establishing “Needs” based sessions for ISMPP U that meet educational gaps for publication professionals. |
 |
Shula Pollard, PhD, ISMPP CMPP™ Shula Pollard is an experienced medical publication professional with over 10 years of experience in the medical device/pharmaceutical industry across a range of roles, including product management, competitive intelligence, medical writing, and publication planning. Shula holds a PhD in Bioengineering from the University of California, San Diego, and has received the AMWA Essential Skills certificate and ISMPP CMPP™ certification. She currently leads Allergan’s Urology publication strategy & execution as a Publications Manager within the External Scientific Communications group. |
 |
Kenneth Pomerantz, PhD After earning a PhD in Physiology from Georgetown University, he pursued post-doctoral training at Columbia University College of Physicians and Surgeons. He later held the rank as Assistant Professor at Cornell University Medical College, in the Department of Hematology/Oncology, where he furthered NIH and AHA-funded research efforts in vascular cell biology, pathology, and molecular biology. Over his academic career, he published 40 scientific publications. From 1996 to 2005, Dr. Pomerantz led domestic strategic publication planning for the Cardiovascular, Metabolic, Oncology and Hematology Portfolios, and global scientific publication planning to support the Men's Health portfolio at the Bayer Corporation. Dr. Pomerantz joined Boehringer Ingelheim Pharmaceuticals Inc. in 2012 to lead the Medical Publications Group. As Director of this Group, he provides strategic and tactical direction for the Medical Publication function within the Department of Clinical Development and Medical Affairs, and in support of US and Global stakeholders. |
 |
Andrew Powrie-Smith Andrew Powrie-Smith is Communications Director at EFPIA, the European Federation of Pharmaceutical Industries and Associations. He previously worked for ABPI, the Association of the British Pharmaceutical Industry, where he served as a Director responsible for the creation and delivery of the association's reputational strategy, as well as for the management of the ABPI Scotland office team. Andrew Powrie-Smith is also a former Director of the British Lung Foundation, after working in the UK and abroad for the British Red Cross, Amnesty International and Scope. |
 |
Monica Ramchandani, PhD |
 |
Charles Rosenblum, MS, PhD Charles is currently a Director of Publications Management within Global Scientific and Medical Publications Department, at Merck & Co., Inc. He serves as Primary Care lead, supervising the Diabetes, Cardiovascular, Neurology and Immunology areas. He has supported publication activities for clinical trials performed by Academic Research Organizations including The Duke Clinical Research Institute, The TIMI Study Group and The University of Oxford Diabetes Trial Unit. Charles has worked in the medical communications area for 8 years. Prior to this, he was a basic researcher for many years within pharma. He received an M.S. in Nutritional Biochemistry from Penn State and Ph.D. in Genetics and Microbiology from Rutgers University. Charles is a member of ISMPP and serves on the ISMPP U committee. |
 |
Sara Rouhi, MS Sara Rouhi has worked in scholarly publishing for seven years and manages sales and outreach in North America for Altmetric.com. She speaks and runs workshops on metrics in practice and the scholarly publishing process at library and scholarly publishing conferences worldwide. She is an active member of the Society of Scholarly Publishing's Education Committee and currently runs their Librarian Focus Group program. She was awarded SSP's Emerging Leader Award in 2015. Before working at Altmetric, she managed outreach and training for ACS Publications, working with librarians to help explain and clarify ACS Publications’ policies, products, and services. Sara conceived of and launched the ACS on Campus program, spearheaded the ACS Publications library summit expansion, and managed the ACS Publications Customer Advisory Panel. Follow her @RouhiRoo and https://www.linkedin.com/in/sararouhi |
 |
Barbara Rowe, MA Barbara Rowe is a Global Publication Director at AstraZeneca in Gaithersburg, Maryland, where she has been employed for almost 8 years. Prior to AstraZeneca/MedImmune she worked for 18 years at Johnson and Johnson in several different functions including sales, sales management, customer service and Medical Education. In her role in publications Barbara has been involved with many of the policy updates, review process guidance, operations, acquisitions, divestitures and overall publication management. She is an active member of ISMPP and currently on the Program Committee. |
 |
Nathan Rustay, PhD Nathan Rustay received his PhD in Behavioral Neuroscience from Oregon Health & Science University. After completing post-doctoral work as a Fellow at the National Institutes of Mental Health, he joined the neuroscience drug discovery group at Abbott Laboratories. After several years in R&D, he moved into Global Medical Publishing, supporting the publication efforts of the neuroscience and neurology product development teams, with positions of increasing responsibility from medical writer to publications manager. In November 2013, he moved to Impax Laboratories, Inc. in Hayward, CA, to lead the publications activities for their Specialty Pharma division. |
 |
Andrew Sakko, PhD, ISMPP CMPP™ Andrew Sakko is a Certified Medical Publication Professional (CMPP), with over 8 years of practical experience leading the development and execution of effective strategic publication plans in the Asia-Pacific region, achieved through several roles, including Medical Communications Manager at Bristol-Myers Squibb and Principal Medical Writer at inVentiv Health Clinical. In his current role at inVentiv Health Clinical, Andrew leads the execution of publications in emerging markets for clients. As a result of this work, he has developed over 75 manuscripts, abstracts, oral presentations and posters in the past two years that have disclosed data derived from global clinical trials, health outcomes studies and real-world research. Andrew has a PhD in clinical oncology, is Secretary for the Asia-Pacific Education Task Force for the International Society of Medical Publication Professionals, and acts as a volunteer mentor for candidates preparing for the CMPP exam. |
 |
Grannum Sant, MD, FRCS, FACS Dr. Sant is Professor of Urology, Tufts University School of Medicine, Boston and Founder and Principal of Sant Consulting LLC. He also serves as Chief Medical Advisor to Link Health. Prior to these positions, Dr. Sant was the former Head of US Medical Affairs (Oncology and Urology) at Sanofi US and Head of Global Medical Affairs (Rare Diseases) at Genzyme. He served as an editorial Board Member of 7 journals, editor of 10 Journal Supplements and 2 textbooks of urology. Dr. Sant has also authored over 120 peer-reviewed publications. |
 |
Carol Sanes-Miller, MS, ISMPP CMPP™ Carol Sanes-Miller has been active in biomedical communications for more than 30 years, and has been involved in publication planning since 1992. In late 2014, Carol joined Baxter Healthcare in Deerfield, IL as Senior Manager, Global Medical Communications. Prior to Baxter, Carol spent 2 years as Director of Scientific Content at Vision2Voice, a small marketing communications agency based in Deerfield, IL. She also worked for 4 years as a Global Publications Manager, commuting weekly to AstraZeneca in Wilmington, Delaware, where she managed publications and symposia for diabetes and cardiovascular products. From 2000 to 2008, Carol worked for Takeda Pharmaceuticals North America in Deerfield, IL, where she held various positions from Senior Medical Writer to Manager of Strategic Publications, development compounds, gastroenterology and cardiovascular science, and managed publication plans in the therapy areas of sleep, oncology, sepsis, endometriosis, gastroenterology and lipid-lowering. Before joining Takeda, Carol spent 8 years as Managing Medical Editor with Discovery International, a medical communications company then located in Deerfield. While at DI, she developed publication strategies and plans, promotional and CME materials, publications and presentations for pharmaceutical company clients. Her professional experience also includes nearly ten years as in-house editor at Rush-Presbyterian-St. Luke's Medical Center in Chicago, where she supported academic publication development in the departments of pathology, surgical nursing, internal medicine, and the Office of the Dean. For 3 years, Carol was Managing Medical Editor at Publications International, publishers of Consumer Guide®, where she developed consumer-targeted books and magazines on topics including family health, fitness, exercise, diet and prescription drugs. Carol has been an active member of ISMPP since its inception, serving on the Best Practices Committee, co-chairing the subcommittee on publication strategy development, and as a member of the CMPP Board (2010-2014), including 2 years on the executive committee and as Board Chair from 2013-2014. Carol is a co-author of GPP2 and the recently submitted GPP3. Carol holds a BS in Biology from Northwestern University and an MS in Biology from Northeastern Illinois University. She lives in suburban Chicago with her husband, youngest son, and super puppy, Izzy. |
 |
Brian Scheckner, PharmD, BCPP, ISMPP CMPPTM |
 |
Suzann Schiller, MA |
 |
Anita Schmid, PhD Anita Schmid, PhD, associate director of scientific communications for solid tumors, Celgene, is responsible for the Abraxane development program’s publication plan and execution for gastrointestinal diseases. Anita originally joined Abraxis BioScience in 2008 as a medical writer, which was later acquired by Celgene, and at that time she was responsible for the development of peer-reviewed publications and conference presentations for Abraxane in breast cancer, lung cancer, pancreatic cancer, and melanoma. Prior to Abraxis BioScience, Anita worked for Allergan and Kendle International. Anita was trained as a neuroscientist at the University of Southern California, her research investigated the neural circuits for reinforcing behavior, and in the last 10 years she has been working in the medical communications profession for the pharmaceutical industry. |
 |
Aruna Seth, PhD, ISMPP CMPP™ Aruna Seth is a Scientific Strategy Lead at Envision Pharma Group, the current co-Chair of the ISMPP Annual Meeting Program Committee and At-Large Member of the ISMPP Board of Trustees. She previously served for 2 years as Chair of the Standards and ISMPP U Committees. Aruna has been in the publication planning arena for over 15 years and has supported, and continues to be involved in providing medical and strategic expertise for, global pre-launch, launch, and post-launch publication planning/communications programs. Aruna obtained her PhD in immunology and has communications experience/interest in several therapeutic areas including psychiatry, neurology, and immunology/infectious diseases. During her doctoral and post-doctoral work, Aruna conducted research in autoimmunity, aging, tumor immunology, malaria, and human/simian acquired immunodeficiency-related projects and presented/published her work in these areas. Aruna is an ISMPP Certified Medical Publication Professional™ (CMPP). |
 |
Brian P. Sharkey, JD Brian P. Sharkey is a Vice President with Porzio Life Sciences, LLC. Mr. Sharkey collaborates with company directors, managers, and regulatory professionals to maintain the content of our products and services. Mr. Sharkey focuses on international transparency laws, codes, and regulations affecting the life sciences industry. Specifically, he analyzes the reporting obligations that companies have under governmental regulatory schemes or industry self-regulation in countries outside the United States and counsels clients on how to comply with them. Mr. Sharkey has also been involved in the development of Porzio’s International Life Sciences Transparency Database, and has written and spoken extensively on the topic of international transparency. Mr. Sharkey is also a Counsel of Porzio, Bromberg & Newman PC and a member of the firm’s Life Sciences Compliance, Commercialization and Regulatory Counseling Department. In his capacity with the law firm, he concentrates his practice on product liability, mass tort, and governmental affairs. r. Sharkey received a J.D. from Seton Hall University School of Law, magna cum laude, and his B.A. from The College of New Jersey. Mr. Sharkey is recognized on the New Jersey Super Lawyers "Rising Stars" List, 2007, 2009 - 2015. |
|
Charlotte Singh Bio coming soon |
|
 |
Catherine Skobe, MPH, MT (ASCP) Catherine Skobe has been a Director on the Publications Management Team at Pfizer since 2007. Prior to Pfizer, she worked on medical publications at IntraMed, a division of Sudler & Hennessey. Catherine also worked at Becton Dickinson in clinical research and at the University of North Carolina Hospitals in the clinical chemistry laboratory. Catherine has served on the ISMPP Ethics Committee since 2011. She has been a faculty member on several ISMPP workshops. She has presented at TIPPA, DIA, and other meetings. Her current areas of interest beyond medical publication ethics are in enhanced publications and exploring social media via alternative metrics as it relates to medical publications. Catherine earned her BS in Medical Technology from the University of North Carolina at Chapel Hill and received her certification as a Medical Technologist from the American Society of Clinical Pathology. She holds a MPH with a concentration in Community Health Education from Hunter College. |
|
Craig Smith Bio coming soon |
|
 |
Richard Smith, PhD Richard Smith worked at the British Medical Journal for 25 years, and for 13 of those years—from 1991 to 2004—he was the editor in chief of the BMJ and chief executive of the BMJ Publishing Group. The winner of three awards for journalism, he has written for dozens of journals in addition to the BMJ and has written widely for the lay press. Richard also worked as a television doctor for six years, four of them for the BBC, and he has made several television programmes. Richard was a member of the board of the Public Library of Science, which aims to make all research open access, and the editor of Cases Journal (a journal that aimed to publish tens of thousands of case reports a year and gather them in a database) and is chair of the Cochrane Library Oversight Committee and was a member of the UK Panel on Research Integrity. He now blogs regularly for the BMJ. His book, “The Trouble with Medical Journals,” summarises what he learnt in his years as an editor. He is also working with F1000, which has a new way to publish science controlled by scientists rather than editors. Currently Richard is chair of the board of trustees of icddr,b [formerly International Centre for Diarrhoeal Disease Research, Bangladesh], which is one of the largest health research institutions in a low income country. An honorary professor at Imperial College London and the University of Warwick, Richard is also chair of the board of Patients Know Best (a start up that uses information technology to improve doctor patient partnership). Having qualified in medicine in Edinburgh, he began his career working in hospitals in Scotland and New Zealand. In 1989-90 he gained a degree in management science from the Stanford Business School in California. Made a Commander of the British Empire in 2000, he comes from a family of comedians and loves making soup, porridge, marmalade, and trouble. |
|
Mark Springer Bio coming soon |
|
 |
Chuck Stevens, JD, MBA Charles (Chuck) Stevens has over 20 years of bio-pharma industry experience, including responsibility for strategic reimbursement, pricing, public and private payer strategy, product distribution/channel management, and pharmacoeconomics for both commercialized and non-commercialized products. At PAREXEL, Chuck is responsible for leading the Reimbursement & Market Access (RMA) practice, including management of all reimbursement, market access, tactical reimbursement support helplines and PAP’s (Patient Assistance Programs), designed to provide workable solutions to support commercial success and patient access to therapy. He has specialized expertise in hematology, oncology, HIV/AIDS, addiction medicine, gastroenterology and urology. Before joining PAREXEL, Chuck held commercial positions of increasing responsibility at Cephalon Oncology, Cell Therapeutics, Genetics Institute (Wyeth Oncology), and Abbott Laboratories. He has a BS (Cum Laude) in Business Administration from Northeastern University, an MBA from Clark University, and a JD (Cum Laude) from Suffolk University Law School. He also attended the Massachusetts Senior Executive Program at Harvard University’s John F. Kennedy School of Government. Chuck is a former Captain in the United States Army Reserve and a veteran of Operation Desert Storm. He is admitted to both the Massachusetts Bar and the United State Supreme Court Bar. Chuck is a frequent presenter at national conferences, including the FDA/CMS Summit, has authored articles on Comparative Effectiveness Research (CER), and has been quoted in publications such as Barron’s, Financial Times, PharmaVoice, FDA Week and the Pink Sheet. |
 |
Sharon Suntag, MS, ISMPP CMPP™ Sharon has over 25 years of experience in healthcare communications, both in the clinical setting and the publication planning arena. In her current position as Medical Director, she is responsible for leading medical affairs activities, which include communications with clinicians, investigators, and patients. Along with the development and execution of scientific communication platforms and publication plans, she provides a hands-on perspective to data analysis and presentation, advisory boards, roundtable and investigator meetings, focus groups, market access communications, patient support programs, and education of team members globally. She is an active member of ISMPP, and has served for several years each on the workshop and program committees, including roles as abstract chair and roundtable chair for the annual meeting. Sharon earned a BS in Cell Biology from Cornell University and an MS in Human Genetics from Sarah Lawrence College. She worked as a genetic counselor in both hospital and community settings prior to transitioning into medical communications roles. She has earned board certification in genetic counseling, and earned the CMPP credential in 2009 and recertified in 2014. |
 |
Jennie Sykes, MBChB, MRCP, FFPM Dr. Sykes is a senior physician with over 20 years Industry experience. She leads the Global Medical Platforms organization within GSK, which includes accountability for Publications & Disclosure Practices; Medical Information; MSL Practices; Medical Operations & Services; and the Focus on the Patient Programme. Dr. Sykes has been instrumental in establishing new ways of working across GSK: ensuring company physicians and scientists engage with the external medical community to advance scientific understanding without any promotional intent. Dr Sykes is a Member of the Royal College of Physicians (UK) and was awarded Membership by Distinction of its Faculty of Pharmaceutical Medicine in 2005, and Fellowship in 2008. Her career in GSK spans 23 years, during which she has held increasingly senior roles in R&D and Medical Affairs. As Global Head of Development for Advair she led the global launch of GSK’s most successful medicine, and the delivery of landmark studies. Dr Sykes was appointed European VP, Clinical Development & Medical Affairs, for Respiratory in 2000; and Regional Medical Director for Emerging Markets and Asia Pacific in 2005 – a role she held for 5 years before her current appointment. |
 |
Aya Takemoto Tokaji, ISMPP CMPP™ Aya was a member of GPP3 steering committee, and is an active ISMPP member in APAC region. As a first ISMPP Certified Medical Publication Professional™ in Japan, she contributes to publication and medical writing related organizations in Japan as a speaker and workshop leader. She currently enjoys privilege of leading numbers of publication professionals to learn and practice the global standards, resulting in some as newly certified ISMPP CMPP™s in the Tokyo area. At McCann Complete Medical in Japan, Aya leads a team of medical communication and publication professionals to plan and execute strategic communications and medical affairs activities for biopharmaceutical and medical device companies. Especially in Japan, her specialized team of publication managers are contributing to the development of a team of publication professionals in the industry. Aya has over 15-years’ experience in medical communications and medical education businesses, and holds a BA in Biology from the University of California at Berkeley and another BA from the Department of Public Health at the University of Tokyo Medical School. |
|
Lorena Telofski, ISMPP CMPP™ Bio coming soon |
|
 |
Jayme C. Trott In her current position with J&J, Jayme oversees global publication planning and execution for CNS and Pain products. In 2009, she led the development of the J&J Cross-Pharma Publication Policy and SOP. As a core member of the J&J Data Sharing Operating Council, Jayme is working to align and update policies related to publications, registry posting, and data sharing. She has worked for J&J since 1999, initially as a field Scientific Liaison, and then as a Therapeutic Area Planner for US Medical Affairs. She is actively involved in International Society for Medical Publication Professionals and is a Certified Medical Publication Professional. Jayme has a Pharm. D. degree from the University of Texas, and Board Certification in Psychiatric Pharmacy Practice. She also holds an MBA from Drexel University. Prior to coming to J&J, Jayme was a clinical pharmacist with research and teaching responsibilities at the University of Texas. |
 |
Stephen Valerio, MS Stephen Valerio is the Therapeutic Area Director for Oncology Publications at AstraZeneca. A Certified Medical Publication Planner and a member of the International Society for Medical Publication Professionals (ISMPP), he has previously served as a member and co-chair of the ISMPP Education Committee and was a member of the Consultation Panel for the Good Publication Practice 2 Guidelines. He has over 15 years of experience in medical publications as a medical writer and working in strategic publications management. Stephen has worked on both national and international publication plans and supported multiple global launches. He has extensive experience in the areas of oncology, psychiatry, neurology, HIV, HCV and metabolism. Prior to joining AstraZeneca, Stephen worked in at Genentech/Roche in a variety of therapeutic areas and has also led the publication planning and scientific services groups at several medical education agencies. Stephen has a MS in Biology from Yale University and a BA with Honors in Biology from Drew University. |
|
Michael van der Veer Bio coming soon
|
|
 |
Hester van Lier, PhD, ISMPP CMPP™ Hester is an experienced team leader at Excerpta Medica, with ten years of experience in medical communications. She has supported international pharmaceutical companies in the development and execution of publication plans at the managerial and content level of products ranging from orphan disease status to blockbuster. Hester is actively involved in the implementation and adherence to Good Publication Practice and a Certified Medical Publication Professional. Since 2006, her expertise focusses on publication plans that integrate medical and Health Economics and Outcomes Research (HEOR) data and insights. Her interests and professional energy go towards shaping interspecialty teams that develop and deliver impactful plans. |
 |
Al Weigel, M.Ed, ISMPP CMPP™ Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. |
 |
Richard Whilte, MS, PhD Richard White is Commercial Director of Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 18 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, has personally authored 17 publications in peer-reviewed journals and 3 white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies, and has also delivered invited presentations and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP (2015/2016) and TIPPA (2014/2015/2016) meetings. Richard co-presented an ISMPP-U webinar on RWE publications that was voted the most popular of 2015. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator’s Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is currently an Honorary Research Associate at Oxford Brookes University, UK. |
 |
Susan Wieting, ISMPP CMPP™ For the past 4 years, Susan has been with Shire International, Switzerland and is currently a Director, Scientific Publications and Therapeutic Area Publication lead for Hereditary Angioedema and Lysosomal Storage Diseases. Susan is originally from California and moved to Europe in 2002 to start her career in medical writing and, subsequently, as a publication planning professional. She has 14 years of medical communication experience in academia, non-profit organizations and the pharmaceutical industry. As a Publication Lead, her areas of expertise include oncology (cervical cancer), vaccines, nephrology, neurology and rare diseases. Susan has a BSc in human physiology from San Francisco State University, a Master’s degree in Sports Administration from the EPFL, Geneva and is an ISMPP Certified Medical Publication Professional. She is a recent member of the ISMPP Medical Society and Education task force. |
 |
Sharon Willis, ISMPP CMPP™ Sharon Willis joined the International Society of Medical Publication Professionals (ISMPP) as Credentialing Director in July 2015. She is responsible for all aspects of the Certified Medical Publication Professional (CMPP) program, including certification exam development and delivery, recertification program and implementation, certification-related US, European, and other regional ISMPP meeting activities, and marketing of the Certification Program. She also manages the yearly ISMPP Certification Board elections with the CMPP Board Nominating Committee and works with Certification Board Directors in guiding related ISMPP activities with the Credentialing and Recertification Committees. Lastly, she manages the Certification Program annual budget in collaboration with the ISMPP Treasurer. Sharon has been an ISMPP CMPP™ since 2010. Prior to working at ISMPP, Sharon served in client services for more than 10 years, including working with Peloton Advantage, LLC, SCI Scientific Communications and Information and Helix Medical Communications LLC. She is experienced in all facets of global and domestic publication planning including strategic and tactical support. Sharon’s therapeutic area experience includes oncology, surgery, central nervous system disorders, infectious disease, and hemophilia. |
 |
Karen Woolley, PhD, ISMPP CMPP™ Karen has spent more than 25 years immersed in the medical publications sector within both academic and industry environments in North America and the Asia Pacific region. Karen serves on ISMPP’s Board of Trustees, chairs ISMPP’s Asia Pacific Advisory Committee, and co-authored the recently published Good Publication Practice 3 guidelines. She is an Honorary Fellow of AMWA, a Life Member of ARCS, and initiated the Global Alliance of Publication Professionals (www.gappteam.org). Karen is the Division Lead of ProScribe – part of the Envision Pharma Group, a technology-led, innovative, scientific communications company with offices in the US, UK, and Asia Pacific (www.EnvisionPharmaGroup.com). Karen and her Envision colleagues have a passion for research on the ethics and value of publication professionals. They have published their research in the world’s highest ranking medical journals (eg, JAMA, PLoS Medicine, Nature Medicine). Karen is invited regularly to speak at regional and international conferences. She provides a unique and engaging perspective on medical publication issues, based on her involvement in academic, hospital, publication sectors. Outside of work, Karen and her family enjoy the outdoors – glacial trekking in Alaska, climbing Mt Kilimanjaro, zip lining in Canada, cycling in France, snowboarding in Japan and, of course, surfing in Australia! |
 |
Yvonne Yarker, PhD, ISMPP CMPP™ Yvonne has over 25 years of experience in medical communications, primarily in content development, publication planning, and publication ethics. She is a coauthor of both the GPP2 and GPP3 guidelines, and has presented at conferences on medical writing and best practices in medical publications. Yvonne works as an independent consultant, providing medical writing, publications planning, and related services. She is the 2016–2017 Chair of the Board of Trustees of ISMPP, and served as Chair of the ISMPP Ethics Committee for the past 5 years. Yvonne is a member of ISMPP, the American Society of Clinical Oncology (ASCO), and the American Medical Writers Association (AMWA). |
